Jocelyn Wiener is an Oakland-based writer who covers health, mental health, poverty and social issues. Her stories have run in the San Francisco Chronicle, The Sacramento Bee, NPR, Kaiser Health News and other publications around the country. She is a former staff writer for The Sacramento Bee.
Jocelyn Wiener
From this contributor
Children with disabilities may wait years for essential medical equipment
Many California children with serious healthcare needs often wait months, or even years, before they receive essential medical equipment.
Children with disabilities may wait years for essential medical equipment
By
Jocelyn Wiener, California Healthline
20 July 2018 | 6 min read
Deportation a constant fear for immigrants with disabled children
As the Trump administration promises to deport a broader range of people, parents of chronically ill children are seeking help to stay in the country.
Deportation a constant fear for immigrants with disabled children
By
Jocelyn Wiener, Kaiser Health News
24 May 2017 | 9 min read
The builders: How parents shaped autism research
A group of savvy parents jump-started autism research in California, but they also set the research agenda.
The builders: How parents shaped autism research
By
Jocelyn Wiener
5 October 2016 | 21 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read